DENMARK - Sofinnova and Gilde invest EUR 17.6m in Ascendis

Ascendis Pharma, a Copenhagen based pharmaceutical company, has attracted a EUR 17.6m series-A financing round. The investment round was co-led by Sofinnova Partners and Gilde Healthcare Partners. Zweite TechnoStart Ventures Fonds GmbH & Co KG also participated in the funding round. The financial injection will be used to strategically broaden the company’s pipeline and to position itself in the space of lifecycle management of high-value and marketed drugs.